Sat Mar 01 16:00:00 UTC 2025: ## Breakthrough Gene Therapy Shows Promise for Maple Syrup Urine Disease
**Worcester, MA – March 3, 2025** – Scientists have achieved a significant breakthrough in the treatment of maple syrup urine disease (MSUD), a debilitating genetic disorder. A new gene therapy, detailed in *Science Translational Medicine*, successfully prevented the recurrence of deadly symptoms in a cow calf born with the disease, offering hope for human patients.
Classic MSUD, caused by mutations preventing the body from breaking down amino acids, currently necessitates strict dietary restrictions or liver transplants. Researchers from the University of Massachusetts Chan Medical School developed a gene replacement therapy using an adeno-associated viral vector to deliver functional gene copies. The therapy proved effective in cell and mouse models, and crucially, prevented death in a calf afflicted with the disease. The calf, treated with a single dose of the bovine-gene-modified therapy, thrived for two years and transitioned to a normal diet.
While further research is needed to assess long-term effects on brain function and behavior, this study represents a major advancement toward a potential cure for the two most common forms of classic MSUD. The team plans to investigate the therapy’s long-term impact on BCKDH levels in the brain and its effects on cognition and behavior. This successful animal trial paves the way for future human clinical trials and offers a beacon of hope for individuals suffering from this life-threatening condition.
First Piper 